Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 38
3rd-Party Payor Claims Barred by Some States' Consumer Protection Laws
Vioxx MDL Special Master Issues Findings on Merck's Privilege Claims
Vioxx MDL Judge: No Conflict Between State-Law Claims and Federal Law
Merck Maintains FDA is Owed Deference Concerning Vioxx Label
Research Watch, Arthritis Drugs, July 2007
7th Circuit Says Pfizer's Removal Under CAFA Was Objectively Reasonable
Iowa Judge Rejects Remicade Parties' Motion to Unseal Daubert Ruling
MDL Plaintiff Accepts $1.6 Million Remittitur Rather than Face New Trial
